Mar 22, 2016

CardioCell Expands Chronic Heart Failure Phase Ila Clinical Trial To MedStar Washington Hospital Center

CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, welcomes MedStar Washington Hospital Center as the newest site for its Phase IIa chronic heart failure (HF) clinical trial. READ FULL ARTICLE